Delivery Order SPE2DB22D9239-SPE2DB24FDF37
Award Date 12/27/23
Potential Completion Date 1/19/24
Potential Value $129K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide EYLEA 2 MG/0.05 ML syringes with a potential value of $20,050.65. This delivery order is part of a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. with DLA to supply pharmaceuticals and medical products to military treatment facilities worldwide. The contract does not have a set-aside designation, and the delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide EYLEA (aflibercept) 2 mg/0.05 ml vials. The $188,097.70 delivery order was issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group with DLA Troop Support Medical to supply a wide range of pharmaceutical and medical products to military treatment facilities worldwide. This contract vehicle has a potential value...
- This is a $29,335.20 firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) to provide EYLEA 2 MG/0.05 ML SYRINGE 0.05ML. The contract has an ultimate completion date of June 27, 2025. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler that specializes in providing a range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product Eylea 2 mg/0.05 ml vial. The contract has a completion date of October 4, 2022 and a potential value of $135,794.00. This delivery order is part of a larger indefinite delivery contract between DMS Pharmaceutical Group and DLA Troop Support Medical to provide a variety of pharmaceutical and medical supplies to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide EYLEA 2 MG/0.05 ML VIAL 0.05ML. This delivery order, valued at $5,253.92, has a completion date of February 1, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of pharmaceutical and medical products to support military treatment facilities worldwide through various DLA contracts and indefinite...
- This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $29,335.20 contract was awarded on June 10, 2025 by the Defense Logistics Agency (DLA) to provide EYLEA 2 MG/0.05 ML SYRINGE 0.05ML medical supplies. The delivery order has a completion date of July 2, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide EYLEA 2 MG/0.05 ML VIAL 0.05ML. This delivery order, valued at $135,794.00, is issued against an existing indefinite-delivery contract held by DMS Pharmaceutical Group to supply pharmaceuticals and medical supplies to military treatment facilities worldwide. The contract does not have a set-aside designation. DMS Pharmaceutical Group is a leading...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product EYLEA 2 MG/0.05 ML VIAL 0.05ML. This delivery order, valued at $134,355.50, was issued against an existing indefinite delivery contract between DMS Pharmaceutical Group and DLA to supply various medical supplies and pharmaceutical products to support military treatment facilities globally. The delivery order has a...
- The Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide EYLEA 2 MG/0.05 ML syringes. The $130,085.76 contract has a completion date of September 14, 2022. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts and Indefinite Delivery Vehicles (IDVs) to supply pharmaceuticals and medical products to the Department of Defense. This delivery order is issued against...
- This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit woman-owned small business. The contract is for the delivery of EYLEA 2 MG/0.05 ML SYRINGE 0.05ML, a pharmaceutical product, with a ceiling value of $58,136.85. It is a firm fixed-price contract with an ultimate completion date of April 2, 2024. DMS Pharmaceutical Group Inc. has a broader indefinite delivery contract (IDV) with DLA,...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB24FDF37Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide EYLEA 2 MG/0.05 ML SYRINGE 0.05ML. The $128,953.90 contract has a completion date of January 19, 2024. This delivery order is part of a larger indefinite delivery contract with DMS Pharmaceutical Group to supply various pharmaceutical and medical products to military treatment facilities globally. The contract does not have a set-aside designation.
Generated 3/27/24, 11:12 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $129.0k | 12/27/23 |